Improving Cyberknife Spinal Stereotactic Radiotherapy in Difficult to Treat Cases (IMPRESS)
NCT ID: NCT05252975
Last Updated: 2022-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2020-07-01
2023-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
NCT06587022
Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases
NCT02512965
Radiotherapy for Solid Tumor Spine Metastases
NCT01752036
Stereotactic Radiosurgery in Treating Patients With Spinal Metastases
NCT00853528
Spinal met_radiosurgery/SBRT Study
NCT01231061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subsets of patients with specific tumour and anatomical characteristics will benefit from improved PTV prescription isodose coverage, reduced spinal cord dose, and organs at risk dose by undergoing either prone or supine setup, planning and treatment. Both prone and supine CT radiotherapy planning scans for patients undergoing spine SBRT treatment will undergo comparison of radiotherapy plans to guide recommendation of prone treatment for future patients.
Patients continue to receive treatment in the proposed position as recommended y their treating physician.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supine
Patients undergo supine setup and imaging for radiation planning
Setup and Imaging for at CT radiation planning
Patients will undergo an additional CT scan acquisition at CT radiotherapy planning in order that all participating patients have a prone and supine CT scan available to compare radiation therapy plans.
Prone
Patients undergo prone setup and imaging for radiation planning
Setup and Imaging for at CT radiation planning
Patients will undergo an additional CT scan acquisition at CT radiotherapy planning in order that all participating patients have a prone and supine CT scan available to compare radiation therapy plans.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Setup and Imaging for at CT radiation planning
Patients will undergo an additional CT scan acquisition at CT radiotherapy planning in order that all participating patients have a prone and supine CT scan available to compare radiation therapy plans.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>18 years of age
* Thoracic, lumbar and sacral spinal metastasis
* Patients suitable to undergo radiotherapy planning CT scans in the prone position (treating physician assessed as having spinal stability).
* All solid tumour types will be eligible
Exclusion Criteria
* Vertebral disease resulting in unstable spinal vertebrae
* Cervical tumours (patients will be unable to have a thermoplastic shell made for the prone position).
* Patients with significant pain on prone lying (to be assessed by physician prior to consent)
* Bilsky epidural score of 2 or greater (see appendix 1)
* Pre-existing musculoskeletal chronic back medical diagnoses that would preclude CT scanning in the prone position.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royal Marsden NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Marsden NHS Foundation Trust
Sutton, Surrey, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCR 5216
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.